Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommendations on the management of pulmonary hypertension in clinical practice.

× No keyword cloud information.

96 in total

1. The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.

Authors: K Schrör; H Darius; R Matzky; R Ohlendorf
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1981-06 Impact factor: 3.000

2. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.

Authors: B A Reitz; J L Wallwork; S A Hunt; J L Pennock; M E Billingham; P E Oyer; E B Stinson; N E Shumway
Journal: N Engl J Med Date: 1982-03-11 Impact factor: 91.245

3. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.

Authors: P G Yock; R L Popp
Journal: Circulation Date: 1984-10 Impact factor: 29.690

4. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.

Authors: L J Rubin; B M Groves; J T Reeves; M Frosolono; F Handel; A E Cato
Journal: Circulation Date: 1982-08 Impact factor: 29.690

Review 5. Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.

Authors: M Packer
Journal: Ann Intern Med Date: 1985-08 Impact factor: 25.391

6. Familial primary pulmonary hypertension: clinical patterns.

Authors: J E Loyd; R K Primm; J H Newman
Journal: Am Rev Respir Dis Date: 1984-01

7. Primary pulmonary hypertension: natural history and the importance of thrombosis.

Authors: V Fuster; P M Steele; W D Edwards; B J Gersh; M D McGoon; R L Frye
Journal: Circulation Date: 1984-10 Impact factor: 29.690

8. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data.

Authors: M Riedel; V Stanek; J Widimsky; I Prerovsky
Journal: Chest Date: 1982-02 Impact factor: 9.410

9. Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation.

Authors: L J Rubin; P Nicod; L D Hillis; B G Firth
Journal: Ann Intern Med Date: 1983-10 Impact factor: 25.391

10. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease.

Authors: E Weitzenblum; A Sautegeau; M Ehrhart; M Mammosser; A Pelletier
Journal: Am Rev Respir Dis Date: 1985-04

31 in total

Review 1. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.

Authors: E Hachulla; J G Coghlan
Journal: Ann Rheum Dis Date: 2004-09 Impact factor: 19.103

2. Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.

Authors: Ralf Ewert; Christian F Opitz; Roland Wensel; Jörg Winkler; Michael Halank; Stephan B Felix
Journal: Clin Res Cardiol Date: 2007-02-15 Impact factor: 5.460

Review 3. Pulmonary hypertension-"state of the art" management in 2012.

Authors: Anita Saxena
Journal: Indian Heart J Date: 2012-03-26

4. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.

Authors: S P McKenna; N Doughty; D M Meads; L C Doward; J Pepke-Zaba
Journal: Qual Life Res Date: 2006-02 Impact factor: 4.147

Review 5. Pulmonary arterial hypertension: a comparison between children and adults.

Authors: R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal: Eur Respir J Date: 2011-03 Impact factor: 16.671

Review 6. The pediatric cardiology pharmacopeia: 2013 update.

Authors: Paul Nicholas Severin; Sawsan Awad; Beth Shields; Joan Hoffman; William Bonney; Edmundo Cortez; Rani Ganesan; Aloka Patel; Steve Barnes; Sean Barnes; Shada Al-Anani; Umang Gupta; Yolandee Bell Cheddar; Ismael E Gonzalez; Kiran Mallula; Hani Ghawi; Suhaib Kazmouz; Salwa Gendi; Ra-id Abdulla
Journal: Pediatr Cardiol Date: 2012-11-29 Impact factor: 1.655

Review 7. [Pulmonary hypertension. Pathophysiology and current concepts of medication therapy].

Authors: H Wilkens
Journal: Anaesthesist Date: 2004-08 Impact factor: 1.041

8. Paradoxical increase of pulmonary vascular resistance during testing of inhaled iloprost.

Authors: M Emmel; B Keuth; S Schickendantz
Journal: Heart Date: 2004-01 Impact factor: 5.994

9. Right ventricle performances with echocardiography and ^99mTc myocardial perfusion imaging in pulmonary arterial hypertension patients.

Authors: Jie Liu; Lei Fei; Guang-Qing Huang; Xiao-Ke Shang; Mei Liu; Zhi-Jun Pei; Yong-Xue Zhang
Journal: Exp Biol Med (Maywood) Date: 2018-05

10. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study.

Authors: Eric Hachulla; Patrick Carpentier; Virginie Gressin; Elisabeth Diot; Yannick Allanore; Jean Sibilia; David Launay; Luc Mouthon; Patrick Jego; Jean Cabane; Pascal de Groote; Amélie Chabrol; Isabelle Lazareth; Loïc Guillevin; Pierre Clerson; Marc Humbert
Journal: Rheumatology (Oxford) Date: 2009-01-27 Impact factor: 7.580